GC35621
CBB1003
Also known as 4-[[3-[4-(4-carbamimidoylbenzoyl)piperazine-1-carbonyl]-5-nitrophenyl]methyl]piperazine-1-carboximidamide
CBB1003 is a novel histone demethylase LSD1 inhibitor with IC50 of 10·54 uM
ChemicalCAS1379573-88-2MW521.57FormulaC25H31N9O4
- CAS number
- 1379573-88-2
- Molecular weight
- 521.57
- Formula
- C25H31N9O4
- Solubility
- Soluble in DMSO
- InChIKey
- SKTVJNLOILHEKO-UHFFFAOYSA-N
- Catalogue number
- GC35621
- Brand
- GLPBIO
Computed properties PubChem CID 57345268 · XLogP -0.3 · TPSA 193 Ų · H-bond donors 4
- XLogP
- -0.3
- TPSA
- 193 Ų
- H-bond donors
- 4
- H-bond acceptors
- 7
- Rotatable bonds
- 6
- Heavy atoms
- 38
SMILES C1CN(CCN1CC2=CC(=CC(=C2)[N+](=O)[O-])C(=O)N3CCN(CC3)C(=O)C4=CC=C(C=C4)C(=N)N)C(=N)N
Computed descriptors from PubChem (CID 57345268), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il